Compassionate treatment of a 51 year old patient with ovarian cancer FIGO IIIC with extensive peritoneal carcinomatosis since October 1997. The patient received paclitaxel and cisplatin from March 97, then docetaxel and carboplatin, doxorubicin, and gemcitabine. Because of progression of disease the patient was offered compassionate treatment with amplitude-modulated electromagnetic fields as of May 05. As seen below, the initial treatment consisting of 15 frequencies (May 05) did not yield any response. Upon re examination, 11 additional frequencies (26) were added to the treatment program in August 05. Because of disease progression, treatment with single agent bevacizumab was initiated in November 05. Interestingly, the CA 125 level had decreased by 200 units prior to the initiation of bevacizumab. Combined treatment with amplitude-modulated electromagnetic fields and bevacizumab resulted in a decrease in CA 125 level from 2140 to 540 in May 06. Treatment was supplemented with cyclophosphamide from March to September 07. The patient was hospitalized with pneumonia and elected to only receive amplitude-modulated electromagnetic fields since September 07. As of April 09, i.e. 50.5 months after treatment initiation the patient has stable disease and is asymptomatic. The numbers above the arrows represent the total number of cancer-specific frequencies included in the treatment program.